Is Sinopharm the Chinese company that NGIO signed
Post# of 36537
PR - Aug 25 2020
"Letter of Intent (LOI) signed with potential partners in China to develop the Ii-Key-SARS-CoV-2 vaccine for China with a proposed $5 million upfront payment upon contract signing and minimum of $400 million if the vaccine is proven successful in clinical trials."